This week's Fierce Biotech is brought to you by Sciensus.

Complimentary Whitepaper Download

Hi E, Check out this comprehensive resource from Fierce Biotech we think you'll like:

Realize your European orphan drug expansion

Unlock the Potential: Tap into Europe's Growing Orphan Drug Market! With 36 million rare disease patients in the EU and a projected market value of $60.25 billion by 2028, the opportunities are immense.

Learn how over 2,730 companies secured orphan designation and discover the keys to navigating diverse regulatory landscapes. U.S. pharmaceuticals, seize the moment to make a difference and thrive in this dynamic market.